---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-294013"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2022-11-29T23:59:59+00:00"
generated_at: "2026-06-21T12:24:15.268069+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Vor Biopharma confirms VOR33 engraftment and hematological protection data to be announced later this year

## Summary
- Vor Biopharma presented at Piper Sandler 34th Annual Healthcare Conference on November 29, 2022.
- Company confirmed upcoming VOR33 data will include engraftment data and hematological protection data.
- Data follows treatment with Mylotarg in at least one patient.
- VOR33 data expected to be announced later this year.

## SEC filing metadata
- accession: 0001193125-22-294013
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2022-11-29T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/0001193125-22-294013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312522294013/d426366d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-294013
- JSON: https://secwatch.observer/filing/0001193125-22-294013.json
- Plain text: https://secwatch.observer/filing/0001193125-22-294013.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.